membranes and induction of surfactant phospholipids are integral processes in maintaining alveolar structures and in generating an alveolar air-surface interface during perinatal development. The biosynthesis of phosphatidylcholine used in these processes appears to be highly regulated at the enzymatic level in mammalian systems.
CTP:cholinephosphate cytidylyltransferase (EC 2.7.7.15) is the principle rate-limiting enzyme required for phosphatidylcholine synthesis, catalyzing the conversion of cholinephosphate to cytidine 5'-diphosphate-choline via the cytidine 5'-diphosphatecholine pathway (1-4). In the lung, cytidylyltransferase activity may be detected in the microsomal and cytosolic subcellular fractions (5, 6) . Cytosolic enzyme appears to exist both as an active high-molecular-weight lipoprotein aggregate (H-form) and as a relatively inactive low-molecular-weight species (L-form) (7- 10) . Prior studies have demonstrated that cytidylyltransferase activity increases significantly during lung development, exhibiting a positive correlation with increased rates of surfactant phospholipid synthesis (7, 1 1 -13).
The regulatory mechanisms underlying the developmental increase in cytidylyltransferase activity remain unclear. The increase in enzyme activity during development might be caused by an increase in the amount of cytidylyltransferase protein: however, limited data are currently available correlating enzyme activity with cytidylyltransferase mass. Alternative mechanisms proposed in various cell culture systems presumably involve an increase in the catalytic activity of preexisting enzyme rather than an increase in total enzyme mass. These mechanisms include dephosphorylation (14) . membrane translocation-activation (15, 16) , interconversion of L-form to H-form (17) , and stimulation by fatty acids (18) and calcium (19) . In the present study, we examined the maturational changes in cytidylyltransferase mass and correlated these observations with changes in activity of the enzyme in fetal. neonatal, and adult rat lung. We report that the fetal lung is characterized by a large amount of cytidylyltransferase enzyme mass: however, only a small fraction of this enzyme is in an active form (H-form). The amount of the active form (H-form) is significantly increased in the fetus after stimulation of the enzyme with phosphatidylglycerol. In marked contrast, the adult lung has a much smaller mass of enzyme, but this enzyme mass is in a more active form (H-form).
MATERIALS A N D METHODS

Animals. Pregnant Sprague-Dawley rats of timed-gestational ages (d 18, d 20, and d 22)
, developmentally staged neonatal rats, and 3-and 6-wk-old adult rats (weighing 150-200 g) were purchased from Charles River Laboratories. Wilmington, MA. All animals were given unrestricted access to food and water and allowed to acclimate in virus-free housing 1 wk before use.
Materials. Phosphatidylcholine Preparation of subcellular jiactions. Pregnant rats of timed gestational ages were anesthetized by intraperitoneal injection with phenobarbital (50 mg/kg). Rat fetuses were surgically removed from their mothers and fetal lungs were resected. Lungs from neonatal and adult rats were also surgically isolated. All organs were homogenized at 5 mL/g tissue in buffer A ( 150 mM NaCI, 50 mM Tris, 1.0 mM EDTA, 2 mM DTT, 0.025% sodium azide, 1 mM PMSF, pH 7.4) using a motor driven homogenizer at 4'C as previously described (20) . The cytosolic fraction was obtained after centrifugation at 10 000 x g for 10 min and 125 000 x g for 60 min. The microsomal pellet recovered after the second spin was resuspended in buffer R [I0 mM Tris-HCI, pH 7.4, 0.25 M sucrose, and 0.1 mM PMSF (2 I)].
Cytidylyltransferase activitv. Enzyme activity was determined by measuring the rate of methyl-I4C phosphocholine incorporation into CDP-choline using a charcoal extraction procedure essentially as described by Weinhold et at. (20) . Briefly, each reaction mixture contained 1.6 mM methyl-I4C phosphocholine, 3.0 mM CTP, 12 mM Mg acetate, 50 mM imidizole, 150 mM KCI, 2 mM EDTA, pH 7.0, and, where indicated, a I: I molar ratio of lipid activator. The lipid activator consisted of a mixture of oleic acid:phosphatidylcholine in a I : 1 molar ratio. The final concentration of each lipid was 500 pm in the reaction mixture. Reactions contained a total assay volume of 100 pL, proceeded for 1 h at 37"C, and were terminated using 10% trichloroacetic acid and 6% charcoal. Reaction rates were linear with respect to time and the amount of enzyme present in the assay mixture. The recovery ofCDP-choline using this method in our laboratory is approximately 7 1 %.
Protein analysis. Protein concentrations were determined using the Bradford method (22) . BSA was used as a protein standard.
Gel electrophoresis. SDS-PAGE was performed as described by Laemmli (23 Partial pzrr~fication of c.vt id.vl~~ltran.~/i~rase,fi.om rat liver. Cytidylyltransferase was partially purified from cytosolic preparations of adult rat livers using N-octyl glucoside as described previously (20) .
Isolation c?fHTform and L+rm bj-gc.l.filtrution. Cytidylyltransferase H-form and L-form species were isolated from fetal (d 20) . neonatal, and adult lung cytosol by gel filtration chromatography using a Superdex column ( 1.6 x 60 cm) equilibrated with buffer A. Approximately 2 1 mg of cytosolic protein were applied to the column, which was eluted at a linear flow rate of 0.375 mL/min at 4°C for optimal resolution. Eluted fractions (1.5 mL) with approximate molecular weight ranges corresponding to cytidylyltransferase H-form and L-form were collected, pooled, and concentrated using Centricell ultrafilters. The molecular sizes for these fractions were estimated by using the following calibration standards: blue dextran 2 x loh D, thyroglobulin 669 000 D, catalase 232 000 D, albumin 67 000 D, and chymotrypsinogen 25 000 D. In addition, confirmation of the H-form and L-forms of cytidylyltransferase in these fractions was performed by demonstrating the characteristic lipid sensitivities of these species (7). All concentrates were stored at 4°C before eel electrophoresis and determination of enzyme activity as described above.
Imm~inodetection ofcvti~j~l~~ltransferase. Total cellular, cytoplasmic, microsomal, and immun~reactive H-form and L-form cytidylyltransferase was determined by Western blot analysis as previously described (2 1,24). After separation using SDS-PAGE. the proteins were electroblotted to a 0.45-pm nitrocellulose filter at a constant voltage of 25 V overnight as described by Towbin et al. (25) . The electroblotting buffer consisted of 0.025 M Tris. 0.192 M glycine, and 20% vol/vol methanol, pH 8.3. After transfer, the filter was washed with a solution of TBS (20 mM Tris, 500 mM NaCI, pH 7 3 , blocked for 2 h with TBS containing 3% gelatin, and then washed twice with TTBS. The filter was then labeled with chicken cytidylyltransferase polyclonal antibody [ I 5 0 0 dilution in TTBS (21)] kindly provided by Dr. D. E. Vance, for 8 h, washed twice with TTBS, and labeled with rabbit antichicken IgG (1: 1000 dilution in TTBS) for 2 h. After rinsing, the antibody-protein conjugates were immunolabeled with "51-protein A for 1 h and the label was visualized after exposure to Kodak XAR2 radiographic film for 4 h a t -70°C. Western blot analysis for the detection of cytidylyltransferase protein was linear in the range from 300 pg to 10 pg as determined by densitometry of the immunoblots.
Activation of c.vtidj~~~ltransfera.~~~ hy phosphatid~~lgI~~cer(11. Stock solutions of phosphatidylglycerol (from egg yolk) were prepared as described previously (26) . Fetal (d 20) and neonatal cytosols at protein concentrations of approximately 8 mg/mL were incubated at 37°C for 30 min with freshly sonicated phosphatidylglycerol in a final lipid concentration of 0.4 mM (26) . After incubation, the lipid mixtures were subjected to gel filtration chromatography and eluted fractions were assayed for cytidylyltransferase H-form and L-form activity and enzyme mass as described above. 3 . lmmunotitration of cytidylyltransferase activity. Aliquots containing constant amounts of cytidylyltransferase antigen from fetal and adult lung cytosol ( A ) and microsomes (B) were incubated with variable amounts of chicken polyclonal cytidylyltransferase antibody for 16 h at 4°C. Each aliquot was labeled with a rabbit antichicken antibody for 24 h. followed by immunoprecipitation for I h with a 10% staphyloccocal protein 4 solution previously suspended in buffer A. The total volume of the reaction mixture was 60 pL. The immunoprecipitated pellet was removed by ~entrifugation at 10 000 x g for 15 min. and 20 p L of supernatant was then assayed for enzyme activity. Enzyme activity was assayed in the presence 3f phosphatidylcholine:oleic acid (a I: I molar ratio) in the reaction mixture. the neonatal period (Fig. 1) . Cytosolic activity subsequently plateaued in the 3-and 6-wk adult lung. In addition, gel filtration chromatography of fetal and adult lung cytosol revealed that enzyme activity was recovered in four eluted fractions: highmolecular-weight H-form (fraction I) and low-molecular-weight L-forms (fractions 11, 111, and IV) corresponding to molecular sizes of approximately >2 x loh [fraction I (void volume)], 232 000-669 000 (fraction II), 1 17 000-2 19 000 (fraction Ill), and 52 000-105 000 (fraction IV). We assayed for enzyme activity in these fractions, both with and without the addition of a lipid activator directly to the reaction mixture ( Fig. 2A and B) . As shown in Figure 2 , the majority of cytosolic enzyme activity was detected in the H-form fractions for adult cytidylyltransferase; enzyme activity was observed at only low levels in the Lform fractions. When assayed with the addition of lipid to the assay mixture, H-form fraction I contained over 86% of the activity in adult lung cytosol (Fig. 2B) . Further, the majority of this enzyme activity was still detected in this fraction even when the assay was performed in the absence of lipid activator (Fig.  2B) . By contrast, in the fetus, cytosolic enzyme activity in the presence of lipid was distributed primarily in the L-form fractions ( Fig. 2A) . L-form fraction 111 contained the major portion (approximately 43%) of the total eluted activity ( Fig. 2A) . In the absence of lipid in the assay mixture, cytidylyltransferase activity in these L-form fractions was undetectable. Microsomal cytidylyltransferase activity was high in the fetus (d 18 and 20) and, thereafter, progressively declined to low levels in the adult rat lung (Fig. 1) .
Immzrnotitration ufcytidj~l.vltrunsfi~ra.~e activitj: The effect of the cytidylyltransferase antiserum on inhibiting lung cytosolic and microsomal activity was evaluated using immunotitration. The antiserum was previously raised in the chicken after immunization with partially purified liver enzyme (21, 27) . Incubation of aliquots containing constant amounts of cytidylyltransferase antigen with increasing amounts of chicken polyclonal antibody revealed that enzyme activity was significantly inhibited in both fetal and adult lung cytosol (Fig. 3A) . The chicken polyclonal antibody neutralized fetal cytosolic activity by 74% and nearly 80% in adult lung cytosol. A similar effect was observed by the antibody against microsomal activity (Fig. 3B) .
Comigration of lung with liver cvtidj~lj~ltran.sfi~ra.~e~ The chicken polyclonal antibody reacted with cytidylyltransferase from liver and lung and the enzyme appeared to be identical by immunoblot studies in both of these tissue preparations. Immunoblotting revealed that the antiserum detected the partially purified enzyme from adult rat liver cytosol (Fig. 4) . Further, the immunoreactive band from liver appeared to comigrate with cytidylyltransferase from fetal lung homogenate (Fig. 4) . Immltnodetection qfc~vtidyI.vltransfirasr. The amount of cytidylyltransferase protein was determined by immunoblotting of whole lung homogenates and cytosolic and microsomal subcellular fractions at similar developmental stages in which enzyme activities were previously measured. lmmunoblotting of rat whole lung homogenates using chicken polyclonal cytidylyltransferase antibody revealed a large amount of enzyme mass during the early stages of fetal lung development [d 18 and 20 ( Fig. 5) ].
Enzyme mass was observed to gradually diminish in each successive developmental period and was detected at relatively low levels in the adult lung. Cytosolic enzyme was also expressed at high levels during the fetal period (d [18] [19] [20] [21] [22] and gradually declined in the neonatal and adult lung, exhibiting a developmental profile similar to that of whole lung homogenates ( and adult lung cytosol. Immunoblotting of fetal cytosolic fractions revealed that the majority of fetal enzyme mass was detected in fraction I11 as L-form enzyme (Fig. 8) . In addition, a substantial amount of immunoreactive enzyme mass was also distributed in L-form fraction I1 (Fig. 8) . Cytosolic fraction I, however, expressed only very low levels of fetal H-form protein despite the fact that significant levels of enzyme activity were observed in this fraction. Adult cytosolic enzyme mass was detected primarily in the relatively higher molecular size fractions. The majority of the enzyme in adult lung was recovered in fraction 11: however, compared with fetal lung, a greater portion of total cytosolic enzyme mass was detected in H-form fraction I (Fig. 8) . In marked contrast to fetal lung, the amount of immunoreactive Lform species as measured in fraction 111 was expressed at very low levels in adult lung cytosol (Fig. 8) .
The amounts of H-form and L-form cytidylyltransferase as demonstrated above by immunoblotting were further analyzed for sp act (nmol/min/mass unit) using densitometric measurements of enzyme mass (Table 1 ). The sp act of cytidylyltransferase both in fetal and adult lung cytosol was observed to be highest in H-form fraction I. Relatively low levels of sp act were detected in the L-form fractions of the fetus and adult.
Activation of c~vtid.vl.vltransferase by phosphatid.vlgl.vcero1. The effect of phosphatidylglycerol on cytidylyltransferase H-form and L-form enzyme activity and enzyme mass was evaluated by incubating fetal and neonatal cytosolic preparations with phosphatidylglycerol, followed by isolation of these cytosolic forms by chromatography. In the fetus, phosphatidylglycerol shifted the activity profile from the relatively lower molecular weight fractions (fractions I1 and 111) to H-form fraction I (Fig. 9) . The previously observed activity in L-form fraction 111 isolated from control cytosols was no longer detected after stimulation with phospholipid. In addition, phosphatidylglycerol decreased activity in fraction I1 by nearly 47% and markedly increased activity in fraction I by 54% relative to control fractions (Fig. 9) . The redistribution of activity induced by phosphatidylglycerol in fetal cytosol was associated with similar changes in enzyme mass (Fig.  10) . The relatively large amount of immunoreactive enzyme observed in fraction I1 and fraction 111 from control fetuses was not detected in fractions isolated from phosphatidylglycerolstimulated cytosols. This enzyme mass was redistributed, in part, to H-form fraction I, where a 2-fold increase in the level of enzyme mass was detected (Fig. 10) .
In the neonatal lung, phosphatidylglycerol also had significant effects on the distribution of the cytosolic forms of the enzyme. Stimulation of neonatal cytosol by phosphatidylglycerol resulted in a marked shift in the amount of enzyme protein from the relatively lower molecular weight fractions (fraction 11, fraction 111) to H-form fraction 1 (Fig. I I) .
Phosphatidylglycerol also redistributed enzyme activity in these cytosolic fractions, although these effects by comparison were relatively small. The majority of cytidylyltransferase activity in neonatal control cytosols was detected in H-form fraction I (Fig. 12) . Phosphatidylglycerol induced a shift in enzyme activity from fraction 11 to fraction I, and these changes were associated with a net increase in the level of activity in fraction I by only 9% (Fig. 12) .
DISCUSSION
Previous studies have shown that there is a pronounced increase in total lung cytidylyltransferase activity during the perinatal period with enzyme activity increasing several fold either during the late alveolar stage (d 22) of fetal lung growth (5, 28) or immediately postbirth in the neonate (7, 12. 13) . The majority of this activity reflects activity in the cytosolic fraction of lung tissue (7. 13). It has also been shown that cytidylyltransferase activity in the microsomal fraction is higher in the fetal lung compared with the adult lung (13) . The findings of the present report are consistent with these prior observations. The purpose of these studies, however, was to determine whether developmental changes in cytidylyltransferase activity were caused by similar changes in enzyme mass. We found that the increases in cytidylyltransferase activity associated with maturation are not mediated by an increase in enzyme mass. In fact, total enzyme mass is highest during the earlier stages of fetal development.
Our studies, as well as prior studies ( 5 , 7. 13). demonstrate that the relative amounts of cytidylyltransferase activity in the cytosolic tissue fraction compared with the microsomal fraction of lung tissue change markedly as a function of maturation. Sp act of cytosolic enzyme increases significantly from the glandular (d 18) to the neonatal (saccular) stage. During this period. the biosynthesis of lung phosphatidylylcholine is critical to facilitate a 3-fold increase in the alveolar surface area (29) and to expand nearly 7-fold the biochemical pool of surfactant phospholipid (30) . We observed a transient decrease in cytosolic enzyme activity that occurred at term gestation (d 22). a finding that has been reported previously (I 2). In the adult lung. cytosolic enzyme remained at relatively high levels compared with the early gestational period. Microsomal enzyme activity, by contrast, substantially declined during successive periods of lung maturation, reaching very low levels in the adult lung.
Weinhold et al. (3 I) previously reported that cytosolic enzyme activity can exist as a highly active lipid-associated multimer (Hform) and as a lipid-independent species (L-form); both species contain the catalytic protein subunit. The molecular weights of these subcellular forms of cytidylyltransferase were estimated, using gel filtration, to be approximately 5 x 10' D for H-form enzyme and 190 000 D for L-form enzyme (9) . Other studies, using sedimentation coefficients, suggested that the molecular weight of the H-form was approximately 284 000 D and that of the L-form was about 97 690 D (3 1). In the present investigation.
cytidylyltransferase activity was assayed in fractions with molecular weight ranges corresponding to molecular size estimates as determined by both these methods. Our results are in agreement with these prior studies and indicate that the majority of enzyme activity in adult lung cytosol is expressed primarily by the Hform species (7). In the adult, nearly 90% of the enzyme activity was expressed as the H-form enzyme. In the fetus, however.
enzyme activity was primarily distributed in the L-form fractions. with nearly 70% of the cytosolic activity detected as L-form enzyme. Unlike H-form enzyme, the enzyme in these L-form fractions was in an inactive form. inasmuch as activity was detected only with the addition of a lipid activator to the assay mixture (Fig. 2 ). Together these findings suggest that cytosolic enzyme activity during lung maturation is converted from a relatively inactive low-molecular-weight species to an active highmolecular-weight lipoprotein complex. Previous studies. to our knowledge, have not evaluated cytidylyltransferase mass as a function of lung maturation and correlated these findings with amounts of enzyme activity in pulmonary tissues. In the present study. enzyme mass in the lung was measured using a chicken polyclonal antiserum that was previously shown to react with the cytosolic forms of liver enzyme (2 1 ). Although the antiserum was initially raised against liver cytidylyltransferase. it was observed to effectively neutralize lung cytidylyltransferase activity in both fetal and adult cytosolic and microsomal preparations (Fig. 3) . Immunoblotting experiments using this antibody demonstrated comigration of lung enzyme with partially purified liver cytidylyltransferase (Fig. 4) . suggesting that these proteins are immunologically similar. Our results further demonstrate that the amounts of total cellular, cytosolic. and microsomal enzyme diminish as lung maturation proceeds. Enzyme activity parallels enzyme mass in the microsomal fraction of lung tissue. This is not true, however. in the cytosol, which contains the bulk of both enzyme mass and activity; enzyme activity increases while enzyme mass decreases as a function of lung maturation.
Recent data suggest that microsomal cytidylyltransferase physically resembles the cytosolic H-form species (32) . Our observation that microsomal protein was not detected in the neonate and adult does not rule out the possibility that cytidylyltransferase antigen was present: most likely it was present at levels below the sensitivity of our assay system. Alternatively, it is possible. although unlikely, that particulate enzyme was not fully recovered after detergent extraction of the microsomal pellet ( 17) . In contrast to the expression of microsomal enzyme. our studies show that high levels of cytosolic enzyme activity are preserved in the adult lung despite relatively low levels of immunoreactive protein. These findings in adult lung contrast with those in fetal lung. which contains much greater amounts of enzyme mass. These observations could be explained by a more efficient conversion of enzyme protein into H-form species in the adult lung compared with the fetal lung. Alternatively. other posttranslational regulatory mechanisms. such as differences in phosphorylation of cytosolic enzyme, could explain these findings ( 14. 33) . In addition. fatty acids ( 17. 18. 34) and anionic phosphoglycerides (26, 35) are potent activators of cytidylyltransferase, and it is possible that these agents interact with the enzyme in a different manner in adult lung than in fetal lung.
To further evaluate the potential regulatory mechanisms underlying cytidylyltransferase function, we measured the amount of cytosolic H-form and L-form enzyme mass in fetal (d 20) and adult lungs. We found that, in adult lung, a substantial portion of the enzyme activity and enzyme mass was expressed as the Hform of the enzyme. In the fetal lung, the enzyme activity was primarily expressed as the L-form of the enzyme. In addition, in marked contrast to the adult lung, over two thirds of fetal cytosolic enzyme mass was detected in the L-form fractions. These findings suggest that the fetal lung contains large amounts 5 10 MALLAMPALLI A N D HUNNlNGHAKE of relatively inactive enzyme. When we further analyzed our data in terms of sp act of enzyme using densitometric measurements of enzyme mass (Table I) , we observed that the relatively low levels of fetal and adult H-form enzyme protein isolated in fraction I expressed the highest levels of catalytic activity. This likely is explained, at least in part, by prior observations that demonstrated that the fraction I species is highly lipid associated (26), accounting for both its large molecular size after separation and its kinetic properties.
Several studies suggest that phosphatidylglycerol may be an important activator of cytidylyltransferase during pulmonary maturation (26, 28, 36, 37) . A 3-fold increase in the lung content of phosphatidylglycerol occurs from the fetal to the newborn period (37) . Phosphatidylglycerol increases phosphatidylcholine production (35) and stimulates cytidylyltransferase activity when this lipid is added either directly to the assay mixture (36. 38) or to the culture medium (35) . The previous finding that this phospholipid is a component of H-form enzyme (26) . together with observations that phosphatidylglycerol converts the inactive form (L-form) to an active species (H-form) as determined by the elution profile of enzyme activity after chromatography (26) . led us to examine whether this lipid activator had similar effects on enzyme mass. We first observed that exposure of fetal lung cytosol to sonicated preparations of phosphatidylglycerol resulted in a similar shift in activity from the relatively lower molecular weight fractions to the active high-molecular-weight species (Fig.  8 ) (26) . Further, these physiologic changes in activity were also associated with a corresponding shift in enzyme mass from Lform to H-form enzyme (Fig. 10) . In the neonate, previous reports have demonstrated a 3-fold increase in the sr, act of cytidylyltransferase after addition of phosphatidylglycerol to lung cytosol (28) . Our results suggest that these stimulatory effects on neonatal enzyme may also involve aggregation of cytidylyltransferase protein into an active high-molecular-weight form. Phosphatidylglycerol in the present study induced a marked shift in enzyme mass from the L-form to H-form species (Fig. 11) . The phospholipid had more limited effects, however, on redistributing enzyme activity because in the 3-d-old neonate cytosolic enzyme was already expressed primarily as the active form (Fig.  12) .
Overall, these studies suggest that the majority of cytidylyltransferase enzyme is highly active in the neonatal and adult lung, whereas most of the enzyme mass is relatively inactive in the fetal lung. This reservoir of physiologically inactive enzyme in the fetus appears to be converted to an active form by anionic phospholipid during perinatal development as the overall size of the lung increases.
